DGAP-News

STADA: Good start in the first quarter of 2013 - organic growth accelerated - Seite 3

most important emerging market Russia has again grown strongly in the first
quarter by 39 percent.'

Development of the market regions
The four STADA market regions recorded varying developments in the
reporting period. Whereas sales of the market region Germany remained
approximately at the same level of the corresponding quarter of the
previous year, sales of the market region Central Europe decreased. On the
other hand, sales were able to show significant growth in the market
regions CIS/Eastern Europe and Asia & Pacific.

In the largest market region Central Europe, sales decreased in the first
quarter of the current financial year by 4 percent to Euro 199.1 million
(1-3/2012: Euro 208.2 million). Sales generated in this market region thus
had a share of 41.7 percent of Group sales (1-3/2012: 47.0 percent). Sales
developed positively in this market region in Italy, France, - as a result
of acquisition - Switzerland, Ireland and Austria.

In the market region CIS/Eastern Europe, sales achieved in the first three
months of 2013 increased significantly - in part due to acquisitions - by
33 percent to Euro 135.7 million (1-3/2012: Euro 101.7 million). Sales
generated in this market region thus contributed 28.4 percent to Group
sales (1-3/2012: 22.9 percent). Russia recorded a strong sales increase of
42 percent applying the exchange rates of the previous year. In euro, sales
recorded growth of 39 percent to Euro 89.9 million due to a negative
currency effect of the Russian ruble (1-3/2012: Euro 64.8 million). In
Serbia, sales increased significantly by 24 percent applying the exchange
rates of the previous year. In euro, sales increased by 22 percent to Euro
20.1 million due to a negative currency effect of the Serbian dinar
(1-3/2012: Euro 16.5 million).

In the market region Germany, - in view of the continued very difficult
framework conditions in the German generics market due to high margin
pressure from discount agreements with public health insurance
organizations - sales in the reporting period were approximately at the
level of the corresponding quarter of the previous year at Euro 126.0
million (1-3/2012: Euro 127.4 million), even though various German sales
companies recorded numerous awards in various tenders for such discount
agreements in financial year 2012. This market region thus had a share of
Group sales of just 26.5 percent (1-3/2012: 28.7 percent).

In the market region Asia & Pacific, sales in the reporting period
increased significantly by 165 percent to Euro 16.2 million (1-3/2012: Euro